X

Vous n'êtes pas connecté

Maroc Maroc - ELECTRICIANSFORUMS.NET - Ala Une - 20/Jan 14:57

3 phase EV Charger on 2 phases.

Articles similaires

UP Police Constable PET 2024 admit card release date out: Check official notice here

times of india - 30/Jan 11:58

The Uttar Pradesh Police Recruitment and Promotion Board (UPPBPB) has announced the UP Police Constable 2024 PET admit card release date. The Physical...

Sorry! Image not available at this time

Tesla EV charger hacked twice on second day of Pwn2Own Tokyo

bleepingcomputer.com - 23/Jan 15:24

​Security researchers hacked Tesla's Wall Connector electric vehicle charger twice on the second day of the Pwn2Own Automotive 2025 hacking contest....

Sorry! Image not available at this time

Tesla Charger Exploits Earn Hackers $129,000 at Pwn2Own

itsecuritynews.info - 23/Jan 13:09

Hackers earned more than $700,000 on the first two days of Pwn2Own Automotive 2025 for EV charger and infotainment exploits. The post Tesla Charger...

CITCO to renovate 2 flagship hotels to drive up revenue in Chandigarh

hindustantimes.com - 23/Jan 22:59

The renovation work will be carried out in phases, with ₹2.5 crore earmarked for Hotel Shivalikview and ₹3 crore for Hotel Mountview

Sorry! Image not available at this time

Second edition of ‘Thomas Partey Tournament’ scheduled for June 2025

ghanasoccernet.com - 29/Jan 17:50

After a successful event in December 2024, the second edition of the Thomas Partey Tournament is scheduled to kick off in June 2025. This exciting...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

menafocus.qa - 05/Feb 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

emiratesnewswire.ae - 05/Feb 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...